MedTrace Pharma A/S: Financial statements 2025
CVR: 36497661
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
MedTrace Pharma A/S (CVR 36497661) has filed annual accounts for 2025. In 2025, the company reported revenue of DKK 1,759,371 and a net result of DKK -35,131,112 compared with DKK -15,355,876 the year before. That is a decrease of 24.6% compared with the year before. The profit margin was -1,996.8%. Equity in the 2025 report amounted to DKK 302,613,643. The solvency ratio was 89.8%. The company had 31 employees in the financial year.
- Revenue
- DKK 1,759,371
- Gross Profit
- DKK -302,168
- Profit/Loss
- DKK -35,131,112
- Equity
- DKK 302,613,643
- Total Assets
- DKK 337,094,886
- Employees
- 31
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | 1.8 mio. | -302 t. | -35.1 mio. | 302.6 mio. | 31 |
| 2024 | 2.3 mio. | 236 t. | -15.4 mio. | 270.1 mio. | 35 |
| 2023 | 2.6 mio. | 2 mio. | -15.1 mio. | 285.2 mio. | 36 |
| 2022 | 2.2 mio. | 1.9 mio. | -37 mio. | 161.2 mio. | 29 |
| 2021 | 1.5 mio. | 374 t. | -17.9 mio. | 93.7 mio. | - |
Official annual report
How creditworthy is MedTrace Pharma A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
As of December 31, 2025, Robert Karl Schier has left the board of directors of MedTrace Pharma A/S.
MedTrace Pharma A/S has won the tender "Kontrakt for levering af vandgenerator med infusionssystem til perfusionsundersøgelse med radioaktivt vand" issued by Region Midtjylland worth 6,800,000 DKK.
As of November 1, 2025, Charlotte Vindfeldt has joined the board of directors of MedTrace Pharma A/S.
As of November 1, 2025, Peter Juul Kristensen is registered as adm. dir. of MedTrace Pharma A/S.
As of October 31, 2025, Peter Juul Kristensen has left the board of directors of MedTrace Pharma A/S.
As of June 12, 2025, Lykke Jul Rømer is registered as director of MedTrace Pharma A/S.
As of June 12, 2025, Ann Kristin Brøgger Led has stepped down as adm. dir. of MedTrace Pharma A/S.
MedTrace Pharma A/S has published its annual report for 2024. Revenue came to DKK 2,334,356, and the net result was DKK -15,355,876.
As of May 21, 2025, is registered as an owner of MedTrace Pharma A/S with an ownership share of 5%.
As of May 1, 2025, Lars Trolle has stepped down as director of MedTrace Pharma A/S.
About MedTrace Pharma A/S
MedTrace Pharma A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2015. The company is registered under the industry Udlejning og leasing af andet materiel, udstyr og andre materielle aktiver til events. The company was previously named MedTrace A/S and Medtrace ApS. The management consists of Peter Juul Kristensen and Lykke Jul Rømer. The board consists of Erik Anders Strömqvist (chair), Cesare Orlandi, Charlotte Vindfeldt and Claus Henrik Berner Møller. The company's owners include Arbejdsmarkedets Tillægspension, MedTravest IV ApS and Swisscanto Private Equity I KmGK. The company has 32 employees (2026). In 2025, the company reported revenue of DKK 1,759,371 and a net result of DKK -35,131,112 compared with DKK -15,355,876 the year before. Equity in the 2025 report amounted to DKK 302,613,643.